ArticleBlood advances2026
Nascent preplatelets and B4GALT1 glycosylation contribute to 5-FU-induced bone marrow recovery.
Article in Blood advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
abstractMegakaryocytes (MKs) are essential for hemostasis, vascular integrity, and hematopoietic stem and progenitor cell (HSPC) support, but their role in bone marrow (BM) recovery has remained underexplored. Here, using a 5-fluorouracil (5-FU) injury model, we identify a transient intramedullary space enriched in extracellular matrix (ECM) proteins such as perlecan, von Willebrand factor, and heparanase, as well as functionally responsive GPIbα+ platelet particles (termed preplatelets). During 5-FU-induced injury, this compartment undergoes dynamic changes, and its resolution depends on the presence of functional preplatelets and ECM components. Consistent with this, platelet depletion further delays restoration of the intramedullary space despite preserved MK numbers, supporting a critical local role for nascent platelets during 5-FU-induced injury. Furthermore, mice lacking β-1,4-galactosyltransferase 1 (B4GALT1) develop persistent thrombocytopenia, exhibit mislocalized and morphologically abnormal MKs, and display expansion of MK-biased HSPCs after 5-FU injury, collectively leading to delayed hematopoietic recovery and expansion of the BM intramedullary space. Single-cell transcriptomic analysis of B4GALT1-/- MK-biased HSPCs at steady state further revealed disruption of adhesion, cytoskeletal, and Notch1-associated programs required for proplatelet formation and MK interactions with ECM components. Our findings reveal a previously unrecognized role for locally retained platelet intermediates and identify B4GALT1-dependent glycosylation as a key regulator of megakaryocyte integrity, platelet production, and hematopoietic recovery after 5-FU-induced myeloablation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.